Dr Nick Finnie is a UK and European Patent Attorney with more than 25 years’ experience advising on patent matters in the Life Sciences sector, both in private practice and in-house, as well as having qualified as a US patent agent and Australian Patent Attorney.

He provides expert IP support to small and large pharma companies such as ADC Therapeutics, Lonza, Novartis where he worked for 11 years in a variety of senior IP leadership roles, including Head of Respiratory Patents, Head of IP for Vaccines and Diagnostics, and Head of IP Asset Management.

Dr Nick Finnie has broad and extensive experience in pharmaceutical patent matters, with particular expertise in biologics, and a detailed inside knowledge of the pharmaceutical industry.

Dr Nick Finnie also worked in-house at Unilever on food-related technologies.

His extensive in-house experience, which brings a good understanding from the inside of how life sciences companies view IP risks and opportunities, enables him to provide highly commercial, business-relevant IP advice and global strategic IP support.

University of Cambridge
MA, PhD, Biochemistry 1989 - 1995

• • BA in Natural Sciences (Part II Biochemistry)
  • Ph.D. in Molecular Biology
  • Activities and societies: Captain, Pistol Shooting team (half blue), Officer Training Corps.